Immunic Inc [NASDAQ: IMUX] closed the trading session at $1440000.0 on 2025-06-24. The day’s price range saw the stock hit a low of $0.6958, while the highest price level was $0.77.
The stocks have a year to date performance of -36.22 percent and weekly performance of -13.71 percent. The stock has been moved at -31.26 percent over the last six months. The stock has performed -23.10 percent around the most recent 30 days and changed -39.49 percent over the most recent 3-months.
If compared to the average trading volume of 1.44M shares, IMUX reached to a volume of 14084267 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Immunic Inc [IMUX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMUX shares is $10.54 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMUX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Immunic Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 25, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on November 25, 2024, representing the official price target for Immunic Inc stock. Previously, the target price had yet another raise to $5, while Leerink Partners analysts kept a Outperform rating on IMUX stock.
IMUX stock trade performance evaluation
Immunic Inc [IMUX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.71. With this latest performance, IMUX shares dropped by -23.10% in over the last four-week period, additionally sinking by -31.26% over the last 6 months – not to mention a drop of -29.20% in the past year of trading.
Immunic Inc [IMUX]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -154.64%, with Return on Assets sitting at -154.64%.
Immunic Inc [IMUX]: Institutional Ownership
There are presently around $44.81%, or 45.43% of IMUX stock, in the hands of institutional investors. The top three institutional holders of IMUX stocks are: BVF INC/IL with ownership of 8.9 million shares, which is approximately 9.15%. AVIDITY PARTNERS MANAGEMENT LP, holding 8.9 million shares of the stock with an approximate value of $$9.88 million in IMUX stocks shares; and AVIDITY PARTNERS MANAGEMENT LP, currently with $$8.1 million in IMUX stock with ownership which is approximately 7.4954%.
